Clinical Trial

Analysis of Efficacy and Outcomes of Immunotherapy for Malignant Tumors: A Prospective Non-interventional Clinical Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The population receiving immunotherapy is heterogeneous. Multiple factors, including combination treatment modalities, influence the immune response, and survival outcomes also vary among individuals receiving immunotherapy. The aim of this study is to develop and validate a clinical prediction model that can predict survival outcomes of immunotherapy for malignant tumors, and to assess the calibration and discrimination of this model in a prospective independent cohort.
Trial Details
NCT Number NCT07665697
Lead Sponsor Sichuan University
Conditions Neoplasms, Drug Therapy, Immune Checkpoint Inhibitors (ICIs)
Enrollment 500 participants
Start Date 2026-06-30
Primary Completion 2029-06-15 (estimated)
Study Completion 2029-06-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-24